CARMEN2026 Transnational Joint Call of the EP PerMed Partnership

The CARMEN2026 transnational joint call under the European Partnership for Personalised Medicine (EP PerMed) funds international research and innovation projects in personalised medicine for cardiovascular, metabolic, and kidney diseases. It involves funding agencies from 27 countries and aims to support consortia developing innovative therapeutic approaches, treatment monitoring, or early risk prediction to prevent disease progression. First-stage pre-proposals are due by 2026-02-10 at 13:00 (Portugal continental time). An online information day is planned for 2025-12-16 from 09:00 to 11:00 (Portugal continental time).

financing for transnational research and innovation projects

Pre-proposals (first submission) due by 10 February 2026; information day on 16 December 2025; detailed information available on the FCT page and related EP PerMed information pages.